Taiwan - Delayed Quote • TWD (070818.TW) Follow Compare 0.0900 0.0000 (0.00%) At close: August 9 at 10:49 AM GMT+8 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 070818.TW 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Winemaker Duckhorn Stock Doubles on Takeover by Private-Equity Firm Butterfly Why Amazon Stock Dropped Early Today Scholar Rock stock surges on positive spinal muscular atrophy treatment data Scholar Rock Stock Quadruples on Positive Trial Data Air Products Stock Is Surging. Here’s Why. Amazon’s Stock Gets a Downgrade. Profit ‘Story Faces Multiple Headwinds.’ Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies Carvana And McDonald's May Have More In Common Than Meets The Eye These Stocks Are Moving the Most Today: Pfizer, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, Duckhorn, and More Duckhorn Portfolio to Be Taken Private by Butterfly Equity in $1.95 Billion Deal Amazon Stock Falls After Rare Analyst Downgrade Update: Scholar Rock's Phase 3 Apitegromab Trial in Spinal Muscular Atrophy Meets Primary Endpoint